Pentair PLC
LSE:0Y5X
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pentair PLC
LSE:0Y5X
|
UK |
|
A
|
Atlas Financial Holdings Inc
OTC:AFHIF
|
US |
|
Kukje Pharma Co Ltd
KRX:002720
|
KR |
|
N
|
Nextage Therapeutics Ltd
TASE:NXTG
|
IL |
|
K
|
Kesko Oyj
F:KEK
|
FI |
|
FUNR
OTC:FUNR
|
US |
|
C
|
Chinney Investments Ltd
HKEX:216
|
HK |
|
Lombard Medical Inc
OTC:EVARF
|
UK |
Wall Street
Price Targets
0Y5X Price Targets Summary
Pentair PLC
According to Wall Street analysts, the average 1-year price target for
0Y5X
is 114.63 USD
with a low forecast of 85.83 USD and a high forecast of 136.46 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 0Y5X's stock price target?
Price Target
114.63
USD
According to Wall Street analysts, the average 1-year price target for
0Y5X
is 114.63 USD
with a low forecast of 85.83 USD and a high forecast of 136.46 USD.
What is Pentair PLC's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Pentair PLC's revenue is
1%.
The projected
CAGR
for the next 3 years is
5%.
What is Pentair PLC's Operating Income forecast?
Projected CAGR
11%
For the last 14 years the
compound annual growth rate for
Pentair PLC's operating income is
7%.
The projected
CAGR
for the next 3 years is
11%.
What is Pentair PLC's Net Income forecast?
Projected CAGR
16%
The
compound annual growth rate
of Pentair PLC's net income for the next 3 years is
16%.
